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in end-stage renal failure
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S. K. Paty, MD, Paul B. Kreienberg, MD, Kathleen J. Ozsvath, MD, Manish Mehta, MD, MPH, and
Dhiraj M. Shah, MD, Albany, NY
Objective: Patients with end-stage renal failure and upper-extremity arterial occlusive disease sometimes have painful
digital ulceration. We evaluated the efficacy of distal bypass grafting from the brachial artery for limb salvage in this
setting.
Methods: All patients with end-stage renal disease with painful digital ulceration or gangrene of the hand seen from 1992
to 2002 were evaluated with clinical examination and noninvasive studies. Those with evidence of occlusive disease
underwent conventional angiography. Individuals with forearm occlusive disease underwent bypass grafting, from the
brachial artery to either the distal radial artery or ulnar artery at the level of the wrist or proximal hand. Follow-up was
scheduled at regular intervals, and included duplex scanning. Limb salvage and bypass graft patency were determined
with life table analysis.
Results: Over 10 years, 18 forearm bypass procedures were performed in 15 patients. The outflow artery was the radial
artery in 15 procedures and the ulnar artery in 3 procedures. Bypass conduit was autogenous in all patients. No patient
had a functioning arteriovenous fistula at bypass grafting; six limbs had previously occluded fistulas. Two bypass grafts
(11%) occluded in the early postoperative period, with resultant progression of gangrene. In the remaining 16 grafts
patency was maintained (mean follow-up, 18 months), with pain control and tissue healing.
Conclusion: Treatment in patients with renal failure with upper extremity occlusive disease may be facilitated with
brachiodistal bypass grafting. Pain control and reversal of progression of hand necrosis can be achieved. (J Vasc Surg
2003;38:1313-5.)
Unlike the lower extremity, the upper extremity is less
likely affected with critical ischemia. Even in the few pa-
tients with symptomatic occlusive disease, involvement of
the axillary, subclavian, and brachial arteries is more com-
mon. Arteries of the forearm are so infrequently affected
that a standard text encompassing upper-extremity vascular
disorders mentions the topic only in brief.1 While virtually
nonexistent in most patients, even those with diabetes,
occlusive disease of the infrabrachial arteries combined with
critical limb ischemia is seen in patients with end-stage renal
failure. The origin of this condition may well involve ath-
erosclerosis, but there is an association with calciphylaxis.2
It is difficult to accurately determine the prevalence of this
problem. Management in these patients may require vascu-
lar reconstructive techniques that are more commonly ap-
plied to the lower extremity. We report our experience with
critical upper extremity ischemia caused by infrabrachial
disease in patients with renal failure.
MATERIAL AND METHODS
Records were reviewed for all patients with end-stage
renal disease with ulceration or gangrene of the upper
extremities from 1992 to 2002. Patients with documented
arteritis, myeloproliferative disorders, immunoglobulin ab-
normalities, disseminated intravascular coagulation, acute
ischemia, embolization, or iatrogenic cause of upper ex-
tremity ischemia were excluded from the analysis, as were
patients with previous radial artery fistulas or patent upper
arm fistulas.
Patients were evaluated initially by clinical examination
coupled with pulse volume recordings and segmental arte-
rial pressure down to the finger level. Blood samples were
obtained and tested for evidence of connective tissue dis-
orders, immunoglobulin abnormalities, and coagulation
disorders.
Patients found to have significant occlusive disease at
noninvasive testing underwent further arterial imaging.
Patients who were determined to have nonreconstructible
disease at angiography were excluded. Disease was deemed
nonreconstructible if no segmental stenosis or occlusion
that could be bypassed was seen at arteriography (true small
vessel disease). In the remainder of patients vein mapping
with ultrasound was performed to locate a suitable venous
conduit. After successful reconstruction, patients with dig-
ital gangrene underwent debridement or amputation of the
affected digits, as necessary.
Data were retrieved through our computerized vascu-
lar registry and medical records. Bypass graft patency was
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monitored at office visits at least every 3 months during the
first postoperative year and at 6-month intervals thereafter.
Follow-up noninvasive studies also included duplex scan-
ning of the forearm graft. Graft patency, salvage, and
survival rates were determined with life table analysis.
RESULTS
Over the 10 years, 15 patients (9 men) and 18 upper
extremities with chronic critical ischemia were found to
have reconstructible disease, and autogenous vein bypass
grafting was performed, with the brachial artery as the
inflow site. Mean age of this patient group was 52 years
(range, 32-74 years). Eight patients (53%) had diabetes.
Fifteen limbs (83%) had digital and hand gangrene; the
remaining 3 limbs (17%) had ischemic digital ulcers. Five
patients (7 limbs) had lower extremity necrotic lesions that
had been previously diagnosed as calciphylaxis. Four pa-
tients (5 limbs) had nonhealing, gangrenous digital ampu-
tation sites. All had evidence of cellulitis and wet gangrene,
despite intravenous antibiotic therapy and aggressive
wound care. In addition, pain was a marked symptom in all
patients. Six additional patients underwent arteriography,
but disease was deemed nonreconstructible. Palmar arch
patency was not used as a criterion for selection and was
completely intact in none of the patients in this series.
All 15 patients had chronic renal failure; 6 patients had
functioning renal transplants, and 3 patients had previous
nonfunctioning renal transplants. Those patients without
functional transplants were maintained with hemodialysis
(n  6) or peritoneal dialysis (n  3). Two patients had
previous brachial arteriovenous loop polytetrafluoroethyl-
ene (PTFE) fistulas that were occluded in the affected limb.
Neither of these limbs showed evidence of stenosis at the
arterial anastomosis.
Arteriography was performed with standard contrast
agents in 12 patients. In those patients with renal trans-
plants but elevated serum creatinine concentration, carbon
dioxide and gadolinium were used to image the arteries. No
limbs had significant axillosubclavian lesions. One limb had
50% stenosis of the brachial artery, related to an old non-
functioning arteriovenous fistula (treated with PTFE patch
angioplasty).
Distal bypass was attempted in all 18 limbs, with autog-
enous vein grafts (upper arm vein in 8 limbs, greater
saphenous vein in 10 limbs). The inflow site for each bypass
graft was the distal brachial artery, at or below the elbow
crease. The outflow vessel was the radial artery in the
anatomic snuffbox in 15 cases (83%), and the distal ulnar
artery in three (17%) cases. Veins were reversed in 9 cases,
and were orthograde in 9 cases.
No perioperative mortality was noted in this series.
Several patients required prolonged hospitalization for
management of associated medical problems. Average
length of stay postoperatively was 7 days.
Two bypass grafts (11%) occluded in the early postop-
erative period. One bypass graft to the ulnar artery oc-
cluded within a few hours of completion, and thrombosis
was believed to be secondary to poor outflow. No revision
was attempted because there was no reasonable alternative
to salvage the bypass graft. The other bypass graft occlusion
occurred 1 week after surgery, and the patient declined a
repeat operation. In the remaining 16 bypass grafts in 13
patients, patency was maintained during follow-up ranging
from 3 to 40 months (mean, 18 months); no graft was
revised. One bypass graft was found at routine duplex
scanning to have a layer of nonocclusive thrombus, but is
patent 23 months postoperatively.
All patent bypass grafts produced improved hand per-
fusion, as assessed at clinical and vascular laboratory testing.
The pulsatility of digital plethysmography, which was uni-
formly flat (class 4 or 5) preoperatively, returned in all cases
postoperatively (class 2 or 3). Digital pressure measure-
ments were not useful, because of heavy arterial calcifica-
tion in this group.
Pain relief was the most notable benefit of successful
bypass grafting. All patients reported significant reduction
in pain and the need for narcotic analgesia. Several patients
were able to leave the hospital, where they had stayed for up
to several weeks simply for pain relief.
Numerous digital amputations and debridement pro-
cedures were performed in limbs with gangrene at presen-
tation. In this group, 28 fingers were amputated, all be-
cause of preexisting gangrene. Twelve involved the distal
phalanx, 12 involved the proximal phalanx, and 4 involved
the entire finger and metacarpal head. While healing of
these amputations was slow, none had to be revised. The
goals of revascularization—pain reduction and limb or
tissue salvage—were achieved in all patients (16 of 18) with
patent bypass grafts.
Postoperative course was poor, as one would expect in
these patients. One of two patients with occluded bypass
grafts died 8 months postoperatively. Of 13 patients with
16 patent bypass grafts, 6 patients with 7 grafts died,
respectively at 18, 20, 23, 24, 27, and 30 months postop-
eratively. The cause of death was cardiac arrest in 5 patients,
during or immediately after dialysis in 4 patients; and
multiple system organ failure with refusal to continue dial-
ysis in 1 patient with 1 bypass graft.
DISCUSSION
Although the incidence of symptomatic distal upper
extremity chronic occlusive disease is decreasingly small in
most large series, it may be larger in patients with chronic
renal failure. Though grossly resembling occlusions seen in
atherosclerotic lower extremity disease, there are clearly
other factors that make some patients more prone to tissue
loss than others. Occlusive lesions in the relatively young
(as compared with the general population with symptom-
atic atherosclerosis) may in some way be related to renal
failure. Inasmuch as several of these patients had known
calciphylaxis, it seems likely that this was also a principal
contributor to development of ischemic lesions. Whether
the entire group of patients had some degree of calciphy-
laxis is difficult to determine, because tissue samples were
not available for retrospective review in most cases. How-
ever, calciphylaxis usually involves medial calcification of
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cutaneous arteries in the range of 0.1 mm in diameter, not
the larger ulnar and radial arteries that were occluded in this
series.3 Calciphylaxis is relatively poorly understood at
present, and its relationship to the arterial calcification in
many patients with and without renal failure is not clear.
What is clear is that calciphylaxis is associated with high
mortality, estimated at 60% to 90%, and many patients
survive only a few months, even with aggressive manage-
ment and parathyroidectomy.2-4 Patient mortality appears
to be related to sepsis from wound infection. Foot gan-
grene in these patients has a high association with death
from sepsis.5 In more proximal leg lesions, the prognosis
may not be quite so dismal.6
Given the atypical nature and location of occlusive
disease, the patients in this series exhibited the familiar
hallmarks of chronic critical ischemia, ischemic pain, ulcer-
ation, and gangrene, and lent themselves to conventional
bypass techniques. Patient evaluation was with conven-
tional arteriography, augmented with nonnephrotoxic con-
trast material when indicated. Bypass procedures, with re-
versed or nonreversed excised vein grafts, were performed
from the distal brachial artery, which was only mildly or
moderately calcified. Distal bypass sites, the radial and ulnar
arteries, were, however, densely calcified and difficult to
manipulate. Performing the distal arteriotomy was the most
difficult part of the procedure, and the two failures in this
series may have been related to disruption of plaque during
this step. Arterial control was achieved with Yasargil clips;
however, continued bleeding during performance of the
anastomosis was common, and was managed with irriga-
tion combined with continuous aspiration.
The results of arterial bypass grafting in this series are
gratifying. Distal lower extremity bypass grafts in patients
with renal failure have not generally had good reported
outcomes, with significantly lower bypass graft patency and
higher limb loss than in patients without renal failure.7-9
Calciphylaxis, noted in many of our patients, has been
reported as a poor prognostic indicator for limb salvage
after lower leg bypass grafting.10 We attribute the satisfac-
tory patency in this group of forearm bypass grafts to use of
short autogenous vein bypass grafts, careful anastomotic
technique, and selection of patients with favorable arterial
anatomy, that is, segmental forearm artery occlusion with
preservation of enough of the palmar arteries to provide
adequate outflow.
In addition, we believe limb salvage was aided by the
upper-extremity location, in that absence of the stress of
weight bearing enabled patients to better protect the fin-
gers and hands from trauma. Furthermore, the principal
indication in this group of patients was not so much tissue
loss as attendant pain and infection, which deterred use of
the limb and hand. A patent bypass graft uniformly reduced
pain to a much more manageable level, which we regard as
the most important benefit of these reconstructions.
Of no surprise, patient survival in this group was rela-
tively poor, given the limited survival of patients with renal
failure in general and of patients with calciphylaxis in par-
ticular.2-4 It is remarkable that no patient with a function-
ing renal transplant died during the study period, whereas
half of the patients maintained with dialysis died during
follow-up.
These bypass procedures have been performed at our
institution only during the past decade, and mainly during
the past 5 years. This does not mean that patients with such
disease were not seen previously. Rather, management was
with cervical sympathectomy, amputation, and pain medi-
cation. However, the increased success achieved with lower
extremity bypass procedures convinced us that some of
these patients might also benefit from revascularization.
Successful bypass produced a significant and gratifying
improvement in the quality of life of these chronically ill
patients with admittedly limited longevity. The relative role
and benefits of bypass surgery versus parathyroidectomy in
patients with renal failure with upper extremity occlusive
disease and calciphylaxis remains to be elucidated.
REFERENCES
1. Williamson K, Edwards JM, Taylor LM, et al. Small artery disease of the
upper extremity. In: Machleder HI, ed. Vascular disorders of the upper
extremity, 3rd edition. New York, NY: Futura, 1998:289-314.
2. Coates T, Kirkland GS, Dymock RB, et al. Cutaneous necrosis from
calcific uremic arteriopathy. Am J Kidney Dis 1995;32:384-91.
3. Fischer AH, Morris DJ. Pathogenesis of calciphylaxis: study of three
cases with literature review. Hum Pathol 1995;26:1055-64.
4. Hafner J, Keusch G, Wahl K, et al. Uremic small-artery disease with
medial calcification and intimal hyperplasia (so-called calciphylaxis): a
complication of chronic renal failure and benefit of parathyroidectomy.
J Am Acad Dermatol 1995;33:954-62.
5. Davis CA, Valentine JR. Wet gangrene in hemodialysis patients with
calciphylaxis is associated with a poor prognosis. Cardiovasc Surg 2001;
9:565-70.
6. Howe SC, Murray JD, Reeves RT, et al. Calciphylaxis, a poorly under-
stood clinical syndrome: three case reports and a review of the literature.
Ann Vasc Surg 2001;15:470-3.
7. Mills JL, Gahtan V, Fujitani RM, Taylor SM, Bandyk DF. The utility
and durability of vein bypass grafts originating from the popliteal artery
for limb salvage. Am J Surg 1994;168:646-51.
8. Edwards JM, Taylor LM, Porter JM. Limb salvage in end-stage renal
disease. Arch Surg 1998;123:1164-8.
9. Chang BB, Paty PSK, Shah DM, Kaufman JL, Leather RP. Results of
infrainguinal bypass for limb salvage in patients with end-stage renal
disease. Surgery 1990;108:742-7.
10. Mureebe L, Moy M, Balfour E, et al. Calciphylaxis: a poor prognostic
indicator for limb salvage. J Vasc Surg 2001;33:1275-9.
Submitted May 7, 2002; accepted May 18, 2003.
JOURNAL OF VASCULAR SURGERY
Volume 38, Number 6 Chang et al 1315
